Skip to main content
Arul Chinnaiyan, MD, Pathology, Ann Arbor, MI

Arul Moli Chinnaiyan MD PhD

Molecular Genetics, Anatomic Pathology, Clinical Pathology


Director of the Michigan Center for Translational Pathology S.P. Hicks Endowed Professor of Pathology and Urology Investigator, Howard Hughes Medical Institute

Join to View Full Profile
  • 1500 E Medical Center DrSpc 5014Ann Arbor, MI 48109

  • Phone+1 734-936-6384

Dr. Chinnaiyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganResidency, Pathology-Anatomic and Clinical, 1999 - 2001
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1999

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2002 - 2021
  • Clinical Pathology
    American Board of Pathology Clinical Pathology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2009
  • Elected Member The American Society for Clinical Investigation, 2006
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • miR-34a Directly Targets tRNAiMet Precursors and Affects Cellular Proliferation, Cell Cycle, and Apoptosis  
    Charles R Cantor, Arul M Chinnaiyan, Proceedings of the National Academy of Sciences
  • Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell Carcinoma  
    Aaron M Udager, Andrew S Mcdaniel, Simpa S Salami, Samuel D Kaffenberger, Jeffrey S Montgomery, Alon Z Weizer, Zachery R Reichert, Ajjai S Alva, Arul M Chinnaiyan, Sco..., European Urology
  • A Precision Oncology Approach to the Pharmacological Targeting of Mechanistic Dependencies in Neuroendocrine Tumors  
    Arul M Chinnaiyan, Helen Remotti, Chanjuan Shi, Roberto Bergamaschi, Michelle K Kim, David C Metz, Nature
  • Join now to see all

Abstracts/Posters

  • Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma Patients
    Arul Chinnaiyan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Integrated Genomic-Transcriptomic Study Highlights Accumulation of Genetic Variants and Activation of Inflammatory Pathways
    Arul Chinnaiyan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Symposia on Cancer Research 2013 
    The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 10/4/2013
  • Symposia on Cancer Research 2013 
    The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 10/4/2013

Press Mentions

  • Certain Gene Signaling Rewires Tumors After Immunotherapy
    Certain Gene Signaling Rewires Tumors After ImmunotherapyJanuary 18th, 2023
  • Researchers Find Link Between Genetic Mutations and Cancer Treatment Resistance
    Researchers Find Link Between Genetic Mutations and Cancer Treatment ResistanceJuly 26th, 2022
  • Ann Arbor Researchers Develop Simple Prostate Cancer Urine Test
    Ann Arbor Researchers Develop Simple Prostate Cancer Urine TestJune 7th, 2022
  • Join now to see all

Grant Support

  • Michigan-VUMC Biomarker Characterization CenterUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Michigan-VUMC Biomarker Characterization CenterUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Exploring Precision Oncology: From Gene Fusions to lncRNAsUNIVERSITY OF MICHIGAN AT ANN ARBOR2018–2025
  • Exploring Precision Oncology: From Gene Fusions to lncRNAsUNIVERSITY OF MICHIGAN AT ANN ARBOR2018–2025
  • Michigan Prostate SPOREUNIVERSITY OF MICHIGAN AT ANN ARBOR2014–2025
  • Identification And Characterization Of Gene Fusions In Lung AdenocarcinomaNational Cancer Institute2011–2012
  • Molecuar Sub-Typing Of Prostate Cancer Based On Recurrent Gene FusionsNational Cancer Institute2009–2012
  • A Systems Biology Approach To The Development Of Cancer BiomarkersNational Cancer Institute2010–2011
  • Tissue/Informatics CoreNational Cancer Institute2008–2011
  • Molecular Sub-Typing Of Prostate Cancer Based On Recurrent Gene FusionsNational Cancer Institute2008–2011
  • Epitomic Biomarkers Of Prostate CancerNational Cancer Institute2004–2009
  • The Role Of Polycomb Group Proteins In Prostate CancerNational Cancer Institute2002–2007

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: